Innoviva Inc INVA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
14.69UNCH (UNCH)
Volume
59,699
Close
14.69quote price arrow up+0.21 (+1.45%)
Volume
576,667
52 week range
11.24 - 16.86
Loading...
  • Open14.49
  • Day High14.71
  • Day Low14.44
  • Prev Close14.48
  • 52 Week High16.86
  • 52 Week High Date01/04/24
  • 52 Week Low11.24
  • 52 Week Low Date04/18/23

Key Stats

  • Market Cap928.809M
  • Shares Out63.23M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta0.58
  • YTD % Change-8.42

KEY STATS

  • Open14.49
  • Day High14.71
  • Day Low14.44
  • Prev Close14.48
  • 52 Week High16.86
  • 52 Week High Date01/04/24
  • 52 Week Low11.24
  • 52 Week Low Date04/18/23
  • Market Cap928.809M
  • Shares Out63.23M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta0.58
  • YTD % Change-8.42

RATIOS/PROFITABILITY

  • EPS (TTM)2.24
  • P/E (TTM)6.55
  • Fwd P/E (NTM)18.14
  • EBITDA (TTM)149.59M
  • ROE (TTM)28.97%
  • Revenue (TTM)310.463M
  • Gross Margin (TTM)86.27%
  • Net Margin (TTM)57.89%
  • Debt To Equity (MRQ)66.11%

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date09/08/2015
  • Div Amount0.25
  • Split Date-
  • Split Factor-

Latest On Innoviva Inc

 

Profile

MORE
Innoviva, Inc. is a diversified holding company with a portfolio of royalties and other healthcare assets. The Company's royalty portfolio consists of respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI) and ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI). Under the Long-Acting Beta2 Agonist (LABA) Collaboration Agreement, the Company is entitled to receive royalties from GSK on sales of...
Pavel Raifeld
Chief Executive Officer
Stephen Basso
Chief Financial Officer
Marianne Zhen CPA
Chief Accounting Officer
Address
1350 OLD BAYSHORE HIGHWAY, SUITE 400
Burlingame, CA
94010
United States

Top Peers

SYMBOLLASTCHG%CHG
AMRN
Amarin Corporation PLC
0.8718-0.0453-4.9395%
CSTL
Castle Biosciences Inc
19.20+0.36+1.91%
IRWD
Ironwood Pharmaceuticals Inc
7.60-0.05-0.65%
TVTX
Travere Therapeutics Inc
5.80-0.19-3.17%
SIGA
SIGA Technologies Inc
8.23-0.28-3.29%